semaglutide dose increase A new study suggests GLP-1s could have a much greater impact beyond obesity and could be tailored to the individual. Learn more at the link in our bio Maximizing Semaglutide: Understanding the Doses

N Engl J Med 347(16):12561261

Because labeling standards vary, it can be difficult to determine actual ingredient exposure, especially when proprietary blends are used

Over this period, researchers reported a decreasing trend in the percentage of new individuals using GLP-1s for T2D and an increasing trend among those with obesity or related conditions who did not have T2D

Their rapid adoption underscores just how quickly the treatment paradigm has shifted

Market Shares of Health Plans Health plans are often characterized into plan types based on their coverage for out-of-network services and their use of primary care gate keeping